What do systematic reviews say?

Summary of findings for exercise plus education vs control

• Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 305 participants
  Very low

Summary of findings: insulin degludec vs insulin detemir

• (Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 454 participants
  Low

Summary of findings: insulin degludec vs insulin glargine

• (Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus 2021 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 1042 participants
  Very low

Summary of findings table ‐ Bladder training vs pelvic floor muscle training (PFMT)

• Bladder training for treating overactive bladder in adults 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 178 participants
  Low

Summary of findings ‐ dual therapy: lumacaftor plus ivacaftor vs placebo

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings ‐ dual therapy: lumacaftor plus ivacaftor (twice daily) vs placebo

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table for metformin plus intensive diet and exercise vs intensive diet and exercise

The review found no eligible studies for this question.

• Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased… 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings ‐ triple therapy: VX‐659‐tezacaftor‐ivacaftor/deutivacaftor vs control

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings 2. Octenidine‐dihydrochloride (OCT) hydrogel dressings vs OCT‐free placebo hydrogel dressings

The review found no eligible studies for this question.

• Hydrogel dressings for donor sites of split‐thickness skin grafts 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs placebo/open control

• Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 2349 participants
  High

Summary of findings table ‐ Therapeutic exercise vs bracing

• Therapeutic exercises for idiopathic scoliosis in adolescents 2024 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 60 participants
  Very low

Summary of findings ‐ Interactive Social Media vs non‐interactive social media

• Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  16 studies · 3792 participants
  Low

Insulin glargine vs NPH insulin

• (Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus 2021 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 1013 participants
  Low

Summary of findings table ‐ Mindfulness based on positive behaviour support vs positive behaviour support

The review found no eligible studies for this question.

• Behavioural and cognitive‐behavioural interventions for outwardly directed aggressive behaviour in people with… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Endoscopic sphincterotomy vs endoscopic papillary balloon dilation

The review found no eligible studies for this question.

• Endoscopic sphincterotomy for adults with biliary sphincter of Oddi dysfunction 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Metformin + megestrol vs megestrol

The review found no eligible studies for this question.

• Metformin for endometrial hyperplasia 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings ‐ triple therapy: elexacaftor‐tezacaftor‐ivacaftor/deutivacaftor vs control

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: oral antioxidants (NAC/GSH) vs placebo

• Antioxidant supplementation for lung disease in cystic fibrosis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 61 participants
  Moderate

Summary of findings: needle acupuncture vs sham

• Acupuncture for epilepsy 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 22 participants
  Low

Summary of findings: needle acupuncture vs valproate

• Acupuncture for epilepsy 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 100 participants
  Low